Intraperitoneal heat perfusion refers to intraperitoneal heat perfusion chemotherapy, which is effective for some peritoneal metastases.
Intraperitoneal heat infusion chemotherapy is to heat the chemotherapeutic drugs with precise constant temperature (the temperature is kept at 42℃-45℃), and then directly circulate and perfuse them into the abdominal cavity, filling the abdominal cavity and maintaining it for a certain period of time, so as to exert a large capacity of removing or shrinking the tumor nodules and inhibiting or eliminating the malignant ascites through the local administration of the drugs.
This treatment can prevent and treat plantation metastasis in the peritoneum, and has the advantages of precise constant temperature, precise localization and precise removal.
The main indications of intraperitoneal heat infusion chemotherapy are gastric cancer, colorectal cancer, bile duct cancer, pancreatic cancer, ovarian cancer, peritoneal pseudomucinous tumor, peritoneal malignant mesothelioma, cancerous ascites, and peritoneal implantation metastasis of other malignant tumors.
There are strict indications and contraindications for the use of intraperitoneal hyperthermic perfusion chemotherapy, which should be decided by specialists after fully evaluating the condition, and should be followed by the doctor’s instructions for necessary rechecking after chemotherapy.